Morgan Stanley Dare Bioscience, Inc. Transaction History

Morgan Stanley

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Aug 16, 2024	BUY	$0.29 - $0.53 $42 - $77	146 New	146 $0
Q4 2023 Feb 13, 2024	SELL	$0.29 - $0.53 $725 - $1,325	-2,500 Reduced 94.48%	146 $0
Q1 2023 May 15, 2023	SELL	$0.87 - $1.36 $56,550 - $88,400	-65,000 Reduced 96.09%	2,646 $2,000
Q4 2022 Feb 14, 2023	BUY	$0.82 - $12.6 $41,000 - $630,000	50,000 Added 283.35%	67,646 $56,000
Q3 2022 Nov 14, 2022	BUY	$1.04 - $12.48 $15,596 - $187,162	14,997 Added 566.14%	17,646 $18,000
Q2 2022 Oct 27, 2022	BUY	$0.94 - $1.76 $2,352 - $4,405	2,503 Added 1714.38%	2,649 $3,000
Q2 2022 Aug 15, 2022	BUY	$0.94 - $1.76 $2,352 - $4,405	2,503 Added 1714.38%	2,649 $3,000
Q1 2022 Oct 27, 2022	SELL	$1.42 - $2.09 $3,554 - $5,231	-2,503 Reduced 94.49%	146 $0
Q1 2022 May 13, 2022	SELL	$1.42 - $2.09 $95,159 - $140,059	-67,014 Reduced 99.78%	146 $0
Q4 2021 Feb 14, 2022	BUY	$1.42 - $2.13 $95,159 - $142,739	67,014 Added 45900.0%	67,160 $134,000
Q3 2021 Nov 15, 2021	BUY	$1.42 - $2.0 $207 - $292	146 New	146 $0

267K

Ticker DARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,820,896
Market Cap $271M
Description
Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in the identifying, developing, and marketing products for women's health in the United States. It develops therapies in the areas of contraception, fertility, and sexual and vaginal health. The company's product includes XACIATO, a single-dose vaginal gel prescription pr...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.